fda tirzepatide shortage to reconsider removal of Eli Lilly weight loss drug from list is tirzepatide on fda shortage

The nutritional prevention of cancer: 400 mcg per day selenium treatment

The most common side effects of Mounjaro include the following: Gastrointestinal (stomach) issues (nausea, reflux, diarrhea, constipation) Increased heart rate Hair loss Fatigue Injection site reactions More serious side effects of this injectable medicine are: Gastroparesis (severely delayed stomach emptying) Bowel obstruction Possible risk of thyroid cancer in certain patients Pancreatitis Hypoglycemia Serious allergic reactions Kidney problems, such as acute kidney injury Changes in vision in diabetic patients with diabetic retinopathy If you experience any of these side effects, please reach out to your healthcare provider immediately or seek emergency medical care

For qualified candidates, benefits of tirzepatide for weight loss include: Effective Weight Loss Clinical trials have shown that tirzepatide can lead to significant weight loss, often surpassing other weight loss medications and lifestyle interventions

Temporary alcohol avoidance during dose escalation may be prudent, as gastrointestinal side effects are most common during this phase

Eligibility reviewed by a licensed clinician

Remove any air bubbles